Alzamend Neuro Stock Alpha and Beta Analysis
| ALZN Stock | USD 0.68 0.01 1.45% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Alzamend Neuro. It also helps investors analyze the systematic and unsystematic risks associated with investing in Alzamend Neuro over a specified time horizon. Remember, high Alzamend Neuro's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Alzamend Neuro's market risk premium analysis include:
Beta 0.41 | Alpha (0.36) | Risk 5.25 | Sharpe Ratio (0.06) | Expected Return (0.29) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Alzamend |
Alzamend Neuro Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Alzamend Neuro market risk premium is the additional return an investor will receive from holding Alzamend Neuro long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Alzamend Neuro. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Alzamend Neuro's performance over market.| α | -0.36 | β | 0.41 |
Alzamend Neuro expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Alzamend Neuro's Buy-and-hold return. Our buy-and-hold chart shows how Alzamend Neuro performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Alzamend Neuro Market Price Analysis
Market price analysis indicators help investors to evaluate how Alzamend Neuro stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Alzamend Neuro shares will generate the highest return on investment. By understating and applying Alzamend Neuro stock market price indicators, traders can identify Alzamend Neuro position entry and exit signals to maximize returns.
Alzamend Neuro Return and Market Media
The median price of Alzamend Neuro for the period between Sat, Jan 20, 2024 and Fri, Apr 19, 2024 is 0.91 with a coefficient of variation of 10.71. The daily time series for the period is distributed with a sample standard deviation of 0.1, arithmetic mean of 0.93, and mean deviation of 0.07. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Acquisition or disposition of Alzamend Neuro securities by Ault Milton C Iii | 01/25/2024 |
2 | Purchase by Ault Milton C Iii of 1220 shares of Alzamend Neuro | 02/02/2024 |
3 | Alzamend Neuro Inc at SRAX Sequire Biotechnology Conference Transcript - GuruFocus.com | 02/05/2024 |
4 | Alzamend Neuro Inc Insider Moves, Fiscal Reports, and Future Earnings Outlook - BNN Breaking | 03/06/2024 |
5 | Alzamend Neuro director Milton Ault III acquires 936k in company stock | 03/28/2024 |
6 | Acquisition by Ault Milton C Iii of 334 shares of Alzamend Neuro at 0.9109 subject to Rule 16b-3 | 04/01/2024 |
7 | Alzamend Neuro director Milton Ault III buys 304 in shares | 04/03/2024 |
8 | Alzamend Neuro shares target cut, retains buy rating - Investing.com UK | 04/15/2024 |
About Alzamend Neuro Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Alzamend or other stocks. Alpha measures the amount that position in Alzamend Neuro has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2024 (projected) | Current Ratio | 12.37 | 2.03 | 3.32 | Net Debt To EBITDA | 1.14 | 0.35 | 0.3 |
Alzamend Neuro Upcoming Company Events
As portrayed in its financial statements, the presentation of Alzamend Neuro's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Alzamend Neuro's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Alzamend Neuro's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Alzamend Neuro. Please utilize our Beneish M Score to check the likelihood of Alzamend Neuro's management manipulating its earnings.
| 21st of March 2024 Upcoming Quarterly Report | View | |
| 31st of January 2024 Next Fiscal Quarter End | View |
Build Portfolio with Alzamend Neuro
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Alzamend Neuro Backtesting, Alzamend Neuro Valuation, Alzamend Neuro Correlation, Alzamend Neuro Hype Analysis, Alzamend Neuro Volatility, Alzamend Neuro History and analyze Alzamend Neuro Performance. To learn how to invest in Alzamend Stock, please use our How to Invest in Alzamend Neuro guide.Note that the Alzamend Neuro information on this page should be used as a complementary analysis to other Alzamend Neuro's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Alzamend Stock analysis
When running Alzamend Neuro's price analysis, check to measure Alzamend Neuro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alzamend Neuro is operating at the current time. Most of Alzamend Neuro's value examination focuses on studying past and present price action to predict the probability of Alzamend Neuro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alzamend Neuro's price. Additionally, you may evaluate how the addition of Alzamend Neuro to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |
Alzamend Neuro technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.